Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1/2a study JOURNAL OF NEUROSURGERY Steinberg, G. K., Kondziolka, D., Wechsler, L. R., Lunsford, L., Kim, A. S., Johnson, J. N., Bates, D., Poggio, G., Case, C., McGrogan, M., Yankee, E. W., Schwartz, N. E. 2019; 131 (5): 1462–72
View details for DOI 10.3171/2018.5.JNS173147
View details for Web of Science ID 000493973300015